O Diav-Citrin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

O Diav-Citrin

Showing results (11-20 of 16) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 16 results.

Clinical Drug Investigation|August 14, 2016

Deferiprone-Induced Agranulocytosis : A Critical Review of Five Rechallenged CasesR Loebstein, O Diav-Citrin, G Atanackovic, et al.

Gastroenterology|January 15, 1998

The safety of mesalamine in human pregnancy: a prospective controlled cohort studyO Diav-Citrin, Y H Park, G Veerasuntharam, et al.

BJOG : an International Journal of Obstetrics and Gynaecology|September 29, 2020

Ondansetron should never be used in pregnancy: Against: Ondansetron in pregnancy revisitedP Damkier, Y C Kaplan, S Shechtman, et al.

Alimentary Pharmacology & Therapeutics|February 5, 2005

The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled studyO Diav-Citrin, J Arnon, S Shechtman, et al.

Reproductive Toxicology (Elmsford, N.Y.)|November 17, 2016

Pregnancy outcomes after maternal varenicline use; analysis of surveillance data collected by the European Network of Teratology Information ServicesJ L Richardson, S Stephens, L M Yates, et al.

Teratology|November 25, 2000

Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studiesL Park-Wyllie, P Mazzotta, A Pastuszak, et al.

Pageof 2

Search research articles

Showing results (11-20 of 16) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 16 results.

Clinical Drug Investigation|August 14, 2016

Deferiprone-Induced Agranulocytosis : A Critical Review of Five Rechallenged CasesR Loebstein, O Diav-Citrin, G Atanackovic, et al.

Gastroenterology|January 15, 1998

The safety of mesalamine in human pregnancy: a prospective controlled cohort studyO Diav-Citrin, Y H Park, G Veerasuntharam, et al.

BJOG : an International Journal of Obstetrics and Gynaecology|September 29, 2020

Ondansetron should never be used in pregnancy: Against: Ondansetron in pregnancy revisitedP Damkier, Y C Kaplan, S Shechtman, et al.

Alimentary Pharmacology & Therapeutics|February 5, 2005

The safety of proton pump inhibitors in pregnancy: a multicentre prospective controlled studyO Diav-Citrin, J Arnon, S Shechtman, et al.

Reproductive Toxicology (Elmsford, N.Y.)|November 17, 2016

Pregnancy outcomes after maternal varenicline use; analysis of surveillance data collected by the European Network of Teratology Information ServicesJ L Richardson, S Stephens, L M Yates, et al.

Teratology|November 25, 2000

Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studiesL Park-Wyllie, P Mazzotta, A Pastuszak, et al.

Pageof 2